Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,069
Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy
Location: Boston MA, Providence RI, New York NY, Philadelphia PA,
Sponsor: Enspire DBS Therapy, Inc.
Sex: All
Age: 21+
Code: NCT05701280
Recruiting
Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study
for
Respiratory Failure
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT01806532
Recruiting
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
for
Ulcerative Colitis
Location: Boston MA, Lebanon NH, Syracuse NY, Pittsburgh PA,
Sponsor: Northwestern University
Sex: All
Age: 18 - 70+
Code: NCT05987852
Recruiting
The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU
for
Feeding Patterns, Sleep, Glucose Intolerance
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT04737200
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients
for
Orthopaedic Related Pain (Musculoskeletal Pain), Opioid, Pain,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07265557
Recruiting
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
for
Familial Partial Lipodystrophy
Location: Boston MA, Philadelphia PA, Ann Arbour MI, Milwaukee WI,
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: All
Age: 13+
Code: NCT06679270
Phase3, Recruiting
Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
for
Atherosclerosis, Stress, Inflammation
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 30 - 65
Code: NCT04496947
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies